Deranged Lipid Profiles and Hepatocellular Carcinoma: Clinical Significance and Association

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 48

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_MISJ-13-2_008

تاریخ نمایه سازی: 25 آبان 1402

چکیده مقاله:

Background: The increasing incidence of hepatocellular carcinoma (HCC) is a challenging health problem worldwide with poor prognosis and limited treatment options. The association between metabolic factors and HCC has been documented, however, there is a shortage of data about this association in our locality. Therefore, we aimed to determine the pattern of lipid profile in cirrhotic patients with HCC and investigate the association between dyslipidemia and HCC.Method: In this case-control hospital-based study, serum lipid profile [total cholesterol, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very-low-density lipoprotein (VLDL)] was determined in ۱۰۰ patients with cirrhosis and ۱۰۰ patients with cirrhosis and HCC. Multivariate analysis of HCC risk factors was done.Results: Metabolic syndrome, hypertriglyceridemia, hypercholesterolemia, high LDL, and combined dyslipidemia were significantly more frequent in HCC patients than non-HCC patients. Low HDL and dyslipidemia were significantly associated with the late HCC stages and LDL levels were significantly correlated with α- fetoprotein levels. There was a tendency towards increasing the values of the other lipid parameters in advanced stages. Metabolic syndrome and combined dyslipidemia were associated with HCC risk.Conclusion: Deranged lipid profiles were common in HCC patients. Metabolic syndrome and combined dyslipidemia could be potential risk factors for HCC and may offer a useful strategy for risk stratification; thus, their control can reduce the HCC burden.

نویسندگان

Ehab Moustafa

Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt

Elham Hassan

Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt

Mohamed Mahmoud

Fever Hospital, Ministry of Health, Sohag, Egypt

Amal Mahmoud

Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt

Mohamed Ghaliony

Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, ...
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. ۲۰۱۸;۳۹۱(۱۰۱۲۷):۱۳۰۱-۱۴. ...
  • Villanueva A. Hepatocellular carcinoma. N Engl J Med. ۲۰۱۹;۳۸۰(۱۵):۱۴۵۰-۶۲. doi: ...
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, ...
  • Le GM, Biagini MR, Tarocchi M, Polvani S, Galli A. ...
  • Argyrou C, Moris D, Vernadakis S. Hepatocellular carcinoma development in ...
  • Reeves HL, Zaki MYW, Day CP. Hepatocellular carcinoma in obesity, ...
  • Yang JD, Mohamed HA, Cvinar JL, Gores GJ, Roberts LR, ...
  • Lewis GF, Rader DJ. New insights into the regulation of ...
  • Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in ...
  • Muntoni S, Atzori L, Mereu R, Satta G, Macis MD, ...
  • Usman H, Rashid R, Ameer F, Iqbal A, Zaid M. ...
  • Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, ...
  • El Zayadi AR, Badran HM, EMF B, Attia Mel- D, ...
  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. ...
  • Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, ...
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood ...
  • George P, Ludvik B. Lipids and diabetes. J Clin Basic ...
  • Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark ...
  • Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. ...
  • Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer ...
  • Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, ...
  • Fernandes JV, Cobucci RN, Jatoba CA, Fernandes TA, de Azevedo ...
  • Sohda T, Iwata K, Kitamura Y, Suzuki N, Takeyama Y, ...
  • Alsabti' EAK. Serum lipids in hepatoma. Oncology. ۱۹۷۹;۳۶(۱):۱۱-۴. doi:۱۰.۱۱۵۹/۰۰۰۲۲۵۳۱۰ ...
  • Qu Q, Wang S, Chen S, Zhou L, Rui JA. ...
  • Alpert ME, Hutt MSR, Davidson CS. Primary hepatoma in Uganda. ...
  • Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, ...
  • Ahaneku JE, Olubuyide IO, Taylor GO, Agbedana EO. Abnormal lipid ...
  • Motta M, Giugno I, Ruello P, Pistone G, Di Fazio ...
  • Casey PJ, Solski PA, Der CJ, Buss JE. p۲۱ras is ...
  • Ooi K, Shiraki K, Sakurai Y, Morishita Y, Nobori T. ...
  • Kita T, Brown MS, Bilheimer DW, Goldstein JL. Delayed clearance ...
  • Jiang J, Nilsson-Ehle P, Xu N. Influence of liver cancer ...
  • Kanel GC, Radvan G, Peters RL. High-density lipoprotein cholesterol and ...
  • Huang J, Li L, Lian J, Schauer S, Vesely PW, ...
  • Moucari R, Asselah T, Cazals-Hatem D. Insulin resistance in chronic ...
  • Wedemeyer I, Bechmann LP, Odenthal M, Jochum C, Marquitan G, ...
  • Serfaty L, Poujol-Robert A, Carbonell N, Chazouilleres O, Poupon RE, ...
  • Menendez JA, Lupu R. Fatty acid synthase and the lipogenic ...
  • نمایش کامل مراجع